BRPI0407680A - métodos para diagnóstico de cáncer e diminuição de metástase por células cancerosas - Google Patents
métodos para diagnóstico de cáncer e diminuição de metástase por células cancerosasInfo
- Publication number
- BRPI0407680A BRPI0407680A BRPI0407680-0A BRPI0407680A BRPI0407680A BR PI0407680 A BRPI0407680 A BR PI0407680A BR PI0407680 A BRPI0407680 A BR PI0407680A BR PI0407680 A BRPI0407680 A BR PI0407680A
- Authority
- BR
- Brazil
- Prior art keywords
- cancer
- methods
- cell metastasis
- diagnosis
- cancer cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Abstract
"MéTODOS PARA DIAGNóSTICO DE CáNCER E DIMINUIçãO DE METáSTASE POR CéLULAS CANCEROSAS". A presente invenção refere-se a uma proteína que é uma proteína marcadora de tumor. Essa proteína pode ser usada para preparar anticorpos que se ligam à proteína marcadora de tumor. Esses anticorpos podem ser usados para reduzir ou eliminar metástase por células de câncer que produzem a proteína marcadora de tumor. Ainda, a invenção provê métodos que podem ser usados para diagnosticar cáncer e metástase por células de câncer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44882803P | 2003-02-19 | 2003-02-19 | |
PCT/EP2004/001556 WO2004074481A1 (en) | 2003-02-19 | 2004-02-18 | Glycorpotein antigen sima135 expressed in metastatic human tumor cells |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0407680A true BRPI0407680A (pt) | 2006-03-01 |
Family
ID=32908657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0407680-0A BRPI0407680A (pt) | 2003-02-19 | 2004-02-18 | métodos para diagnóstico de cáncer e diminuição de metástase por células cancerosas |
Country Status (13)
Country | Link |
---|---|
US (4) | US7589173B2 (pt) |
EP (1) | EP1597367B1 (pt) |
JP (3) | JP2007523836A (pt) |
CN (1) | CN100422328C (pt) |
AT (1) | ATE473279T1 (pt) |
AU (1) | AU2004213568A1 (pt) |
BR (1) | BRPI0407680A (pt) |
CA (2) | CA2787820A1 (pt) |
DE (1) | DE602004027992D1 (pt) |
ES (1) | ES2349128T3 (pt) |
MX (1) | MXPA05008794A (pt) |
PT (1) | PT1597367E (pt) |
WO (1) | WO2004074481A1 (pt) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10242146A1 (de) * | 2002-09-04 | 2004-03-18 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Antikörper zur Identifizierung und/oder Isolierung von hämatopoetischen Stammzellen |
CN100422328C (zh) * | 2003-02-19 | 2008-10-01 | 诺瓦提斯公司 | 在人转移性肿瘤细胞中表达的糖蛋白抗原sima135 |
EP1660531A2 (en) | 2003-08-05 | 2006-05-31 | Novo Nordisk A/S | Novel insulin derivatives |
GB0324656D0 (en) * | 2003-10-22 | 2003-11-26 | Celltech R&D Ltd | A protein involved in ovarian cancer |
US20080008719A1 (en) * | 2004-07-10 | 2008-01-10 | Bowdish Katherine S | Methods and compositions for the treatment of prostate cancer |
WO2006017173A1 (en) * | 2004-07-10 | 2006-02-16 | Alexion Pharmaceuticals, Inc. | Methods for discovering antibodies specific to cancer cells and antibodies discovered thereby |
WO2007005502A2 (en) * | 2005-06-30 | 2007-01-11 | Applera Corporation | Methods and compositions for treating diseases targeting cdcp1 |
JP2007112734A (ja) * | 2005-10-19 | 2007-05-10 | Chugai Pharmaceut Co Ltd | 抗cdcp1抗体を含有する癌細胞増殖抑制剤 |
EP1969004B1 (en) | 2005-12-28 | 2011-08-10 | Novo Nordisk A/S | Compositions comprising an acylated insulin and zinc and method of making the said compositions |
US8264715B2 (en) * | 2006-04-25 | 2012-09-11 | Ricoh Company, Ltd. | Approach for implementing locked printing with remote unlock on printing devices |
US20130136689A1 (en) * | 2007-06-05 | 2013-05-30 | Christian Rohlff | Proteins |
DK2447719T3 (en) * | 2007-02-26 | 2016-10-10 | Oxford Biotherapeutics Ltd | proteins |
WO2008152106A1 (en) | 2007-06-13 | 2008-12-18 | Novo Nordisk A/S | Pharmaceutical formulation comprising an insulin derivative |
WO2010049488A1 (en) | 2008-10-30 | 2010-05-06 | Novo Nordisk A/S | Treating diabetes melitus using insulin injections with less than daily injection frequency |
TW201113037A (en) | 2009-08-28 | 2011-04-16 | Hoffmann La Roche | Antibodies against CDCP1 for the treatment of cancer |
TWI412375B (zh) | 2009-08-28 | 2013-10-21 | Roche Glycart Ag | 人類化抗cdcp1抗體 |
RU2013123515A (ru) | 2010-10-27 | 2014-12-10 | Ново Нордиск А/С | Лечение сахарного диабета с помощью инъекций инсулина, вводимых с различными интервалами |
JP2016519127A (ja) | 2013-04-30 | 2016-06-30 | ノヴォ ノルディスク アー/エス | 新規投与レジメン |
WO2015082446A1 (en) | 2013-12-02 | 2015-06-11 | F. Hoffmann-La Roche Ag | Treatment of cancer using an anti-cdcp1 antibody and a taxane |
MA50134A (fr) | 2016-12-16 | 2020-07-29 | Bluefin Biomedicine Inc | Anticorps anti-protéine 1 contenant un domaine anti-cub (cdcp1), conjugués anticorps-médicament et leurs méthodes d'utilisation |
US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
AU2020377402A1 (en) * | 2019-11-06 | 2022-06-23 | Commonwealth Scientific And Industrial Research Organisation | Binding proteins to CUB domain-containing protein (CDCP1) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69229254T2 (de) * | 1991-10-30 | 1999-09-23 | Idemitsu Kosan Co | Verfahren zur Herstellung von menschlichen Lymphozyten und menschlichen Antikörpern; und so hergestellte Antikörper |
AU4441799A (en) | 1998-06-15 | 2000-01-05 | Research Foundation Of The State University Of New York, The | Monoclonal antibodies that recognize antigens associated with tumor metastasis |
JP2002521055A (ja) * | 1998-07-30 | 2002-07-16 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | 98個のヒト分泌タンパク質 |
WO2002004508A1 (de) | 2000-07-07 | 2002-01-17 | Boehringer Ingelheim International Gmbh | Tumorassoziiertes antigen (b345), gekennzeichnet durch eine aminosäuresequenz wie in seq. id. no. 4 |
US20020142003A1 (en) * | 2000-07-07 | 2002-10-03 | Norbert Schweifer | Tumor-associated antigen (B345) |
US6783969B1 (en) * | 2001-03-05 | 2004-08-31 | Nuvelo, Inc. | Cathepsin V-like polypeptides |
CN100422328C (zh) * | 2003-02-19 | 2008-10-01 | 诺瓦提斯公司 | 在人转移性肿瘤细胞中表达的糖蛋白抗原sima135 |
WO2007134272A2 (en) * | 2006-05-12 | 2007-11-22 | Janssen Pharmaceutica N.V. | Humanized models via targeted mtagenesis with zinc finger nuclease |
-
2004
- 2004-02-18 CN CNB2004800074635A patent/CN100422328C/zh not_active Expired - Fee Related
- 2004-02-18 US US10/781,564 patent/US7589173B2/en not_active Expired - Fee Related
- 2004-02-18 MX MXPA05008794A patent/MXPA05008794A/es active IP Right Grant
- 2004-02-18 CA CA2787820A patent/CA2787820A1/en not_active Abandoned
- 2004-02-18 ES ES04711993T patent/ES2349128T3/es not_active Expired - Lifetime
- 2004-02-18 CA CA002516366A patent/CA2516366A1/en not_active Abandoned
- 2004-02-18 BR BRPI0407680-0A patent/BRPI0407680A/pt not_active IP Right Cessation
- 2004-02-18 JP JP2006501880A patent/JP2007523836A/ja not_active Withdrawn
- 2004-02-18 AT AT04711993T patent/ATE473279T1/de active
- 2004-02-18 DE DE602004027992T patent/DE602004027992D1/de not_active Expired - Lifetime
- 2004-02-18 WO PCT/EP2004/001556 patent/WO2004074481A1/en active Application Filing
- 2004-02-18 EP EP04711993A patent/EP1597367B1/en not_active Revoked
- 2004-02-18 AU AU2004213568A patent/AU2004213568A1/en not_active Abandoned
- 2004-02-18 PT PT04711993T patent/PT1597367E/pt unknown
-
2009
- 2009-09-10 US US12/584,826 patent/US20100158917A1/en not_active Abandoned
-
2010
- 2010-09-06 JP JP2010199239A patent/JP5331071B2/ja not_active Expired - Fee Related
-
2011
- 2011-09-14 US US13/199,975 patent/US20120039891A1/en not_active Abandoned
-
2012
- 2012-10-04 US US13/573,774 patent/US20130142798A1/en not_active Abandoned
-
2013
- 2013-06-19 JP JP2013128709A patent/JP2013241416A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2004074481A1 (en) | 2004-09-02 |
US7589173B2 (en) | 2009-09-15 |
US20040247601A1 (en) | 2004-12-09 |
CA2787820A1 (en) | 2004-09-02 |
US20120039891A1 (en) | 2012-02-16 |
CN1761750A (zh) | 2006-04-19 |
JP2011046712A (ja) | 2011-03-10 |
ATE473279T1 (de) | 2010-07-15 |
ES2349128T3 (es) | 2010-12-28 |
US20130142798A1 (en) | 2013-06-06 |
MXPA05008794A (es) | 2006-03-10 |
JP2013241416A (ja) | 2013-12-05 |
DE602004027992D1 (de) | 2010-08-19 |
CA2516366A1 (en) | 2004-09-02 |
PT1597367E (pt) | 2010-09-02 |
AU2004213568A1 (en) | 2004-09-02 |
EP1597367B1 (en) | 2010-07-07 |
CN100422328C (zh) | 2008-10-01 |
EP1597367A1 (en) | 2005-11-23 |
JP2007523836A (ja) | 2007-08-23 |
US20100158917A1 (en) | 2010-06-24 |
JP5331071B2 (ja) | 2013-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0407680A (pt) | métodos para diagnóstico de cáncer e diminuição de metástase por células cancerosas | |
CY1123400T1 (el) | Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
LTC2100614I2 (lt) | Antikūnas prieš PDGFR-alfa, skirtas naudoti auglių gydymui | |
CU24058B1 (es) | Antagonistas de pcsk9 | |
NO20080362L (no) | CD19-antistoffer og deres anvendelser | |
ATE486610T1 (de) | Anti-glypican-3-antikörper | |
ATE505544T1 (de) | Monoklonale antikörper und einzelkettenantikörper fragments gegen das zelloberflächen prostataspezifische membranantigen | |
TW200639182A (en) | Antibody variants and uses thereof | |
CL2007003649A1 (es) | Un conjugado de molecula asociado a anticuerpo monoclonal humano anti-cd70; composicion que comprende al conjugado de molecula asociado a anticuerpo; metodo de inhibicion del crecimiento de celulas tumorales que expresan cd70. | |
WO2006089230A3 (en) | Human monoclonal antibodies to prostate specific membrane antigen (psma) | |
ATE488530T1 (de) | Internalisierende antikörper spezifisch für das raag10 zelloberflächenziel | |
EA201390146A1 (ru) | Антитела к матриксной металлопротеиназе 9 | |
NZ602220A (en) | Antibodies with ph dependent antigen binding | |
DK3085783T3 (da) | Bispecifikt antistof som substitution for funktionelle proteiner | |
EA200801621A1 (ru) | Антитела, направленные на her-3, и их применение | |
DE602006016344D1 (de) | Für das fibroblastenaktivierungsprotein spezifische antikörpermoleküle und immunkonjugate, die diese enthalten | |
AR067199A1 (es) | Proteinas de union a antigenos que se unen a par-2 | |
CY1115212T1 (el) | Διαμεσολαβηση στην κυτταροτοξικοτητα των κυτταρων που παρουσιαζουν eπιφaneiakh εκφραση της cd44 | |
IL163902A0 (en) | Antibodies against cancer antigen tmeff2 and uses thereof | |
EP2210939A4 (en) | ANTIBODY ANTI-BST2 | |
WO2008136848A3 (en) | Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease | |
CR10143A (es) | Antígenos de ácido des-n-acetil-siálico, anticuerpos para los mismos y métodos de uso en la terapia del cáncer | |
EA200970884A1 (ru) | Способы лечения рака путем введения комбинаций человеческого интерлейкина ил-18 | |
EP2192132A3 (en) | Anti-IL-20, anti-IL22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation | |
WO2008151819A3 (en) | Treatment of tumors using specific anti-l1 antibody |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 13A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |